Postexposure Prophylaxis for Rabies in Resource-Limited/Poor Countries

Advances in Virus Research

Volumn 79, Issue , 2011, Pages 291-307

  Shantavasinkul, Prapimporn ^a   Wilde, Henry ^b  

^a WHO Collaborating Center for Research on Rabies Pathogenesis and Prevention   (Thailand)

^b CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Immunoglobulins; Intradermal vaccination; Postexposure vaccination; Preexposure vaccination; Rabies; Vaccination regimens; Vaccines

Indexed keywords

IMMUNOGLOBULIN; RABIES VACCINE;

BOOK; DEVELOPING COUNTRY; ECONOMICS; HUMAN; METHODOLOGY; POST EXPOSURE PROPHYLAXIS; RABIES;

DEVELOPING COUNTRIES; HUMANS; IMMUNOGLOBULINS; POST-EXPOSURE PROPHYLAXIS; RABIES; RABIES VACCINES;

EID: 79956109340     PISSN: 00653527     EISSN: 15578399     Source Type: Book Series    
DOI: 10.1016/B978-0-12-387040-7.00013-5     Document Type: Book

References (65)

1. Anonymous Human-to-human transmission of rabies via corneal transplant-Thailand. MMWR Morb. Mortal. Wkly. Rep. 1981, 30:473-474.
2. Anonymous Leads from the MMWR. Human rabies despite treatment with rabies immune globulin and human diploid cell rabies vaccine-Thailand. JAMA 1988, 259:25-26.
3. Anonymous WHO recommendations on rabies post-exposure treatment and the correct technique of intradermal immunization against rabies 1997, WHO publication WHO/EMC/ZOO/96.6, p. 1-24.
4. Anonymous WHO Expert Consultation on rabies. World Health Organ. Tech. Rep. Ser. 2005, 931:1-88.
5. Anonymous WHO Expert Committee on biological standardization 2007, World Health Organ Tech Rep Ser1-340, back cover.
6. Anonymous Rabies vaccines: WHO position paper. Wkly. Epidemiol. Rec. 2010, 85:309-320.
7. Baer G.M., Shaddock J.H., Houff S.A., Harrison A.K., Gardner J.J. Human rabies transmitted by corneal transplant. Arch. Neurol. 1982, 39:103-107.
8. Bronnert J., Wilde H., Tepsumethanon V., Lumlertdacha B., Hemachudha T. Organ transplantations and rabies transmission. J. Travel Med. 2007, 14:177-180.
9. Chutivongse S., Wilde H., Supich C., Baer G.M., Fishbein D.B. Postexposure prophylaxis for rabies with antiserum and intradermal vaccination. Lancet 1990, 335:896-898.
10. Chutivongse S., Wilde H., Benjavongkulchai M., Chomchey P., Punthawong S. Postexposure rabies vaccination during pregnancy: Effect on 202 women and their infants. Clin. Infect. Dis. 1995, 20:818-820.
11. Cliquet F., Verdier Y., Sagne L., Aubert M., Schereffer J.L., Selve M., Wasniewski M., Servat A. Neutralising antibody titration in 25, 000 sera of dogs and cats vaccinated against rabies in France, in the framework of the new regulations that offer an alternative to quarantine. Rev. Sci. Tech. 2003, 22:857-866.
12. Dean D.J., Baer G.M., Thompson W.R. Studies on the local treatment of rabies-infected wounds. Bull. World Health Organ. 1963, 28:477-486.
13. Devriendt J., Staroukine M., Costy F., Vanderhaeghen J.J. Fatal encephalitis apparently due to rabies. Occurrence after treatment with human diploid cell vaccine but not rabies immune globulin. JAMA 1982, 248:2304-2306.
14. Fishbein D.B., Sawyer L.A., Reid-Sanden F.L., Weir E.H. Administration of human diploid-cell rabies vaccine in the gluteal area. N. Engl. J. Med. 1988, 318:124-125.
15. Gacouin A., Bourhy H., Renaud J.C., Camus C., Suprin E., Thomas R. Human rabies despite postexposure vaccination. Eur. J. Clin. Microbiol. Infect. Dis. 1999, 18:233-235.
16. Hemachudha T., Rupprecht C.E. Rabies. Principle of Neurologic Infectious Disease 2004, 151-174. McGraw-Hill, New York. M. Karen, M. Karen, L. Roos (Eds.).
17. Hemachudha T., Mitrabhakdi E., Wilde H., Vejabhuti A., Siripataravanit S., Kingnate D. Additional reports of failure to respond to treatment after rabies exposure in Thailand. Clin. Infect. Dis. 1999, 28:143-144.
18. Houff S.A., Burton R.C., Wilson R.W., Henson T.E., London W.T., Baer G.M., Anderson L.J., Winkler W.G., Madden D.L., Sever J.L. Human-to-human transmission of rabies virus by corneal transplant. N. Engl. J. Med. 1979, 300:603-604.
19. Jaijaroensup W., Tantawichien T., Khawplod P., Tepsumethanon S., Wilde H. Postexposure rabies vaccination in patients infected with human immunodeficiency virus. Clin. Infect. Dis. 1999, 28:913-914.
20. Johnson N., Phillpotts R., Fooks A.R. Airborne transmission of lyssaviruses. J. Med. Microbiol. 2006, 55:785-790.
21. Kamoltham T., Tepsumethanon V., Wilde H. Rat rabies in Phetchabun Province, Thailand. J. Travel Med. 2002, 9:106-107.
22. Khawplod P., Wilde H., Chomchey P., Benjavongkulchai M., Yenmuang W., Chaiyabutr N., Sitprija V. What is an acceptable delay in rabies immune globulin administration when vaccine alone had been given previously?. Vaccine 1996, 14:389-391.
23. Khawplod P., Wilde H., Yenmuang W., Benjavongkulchai M., Chomchey P. Immune response to tissue culture rabies vaccine in subjects who had previous postexposure treatment with Semple or suckling mouse brain vaccine. Vaccine 1996, 14:1549-1552.
24. Khawplod P., Benjavongkulchai M., Limusanno S., Chareonwai S., Kaewchompoo W., Tantawichien T., Wilde H. Four-site intradermal postexposure boosters in previously rabies vaccinated subjects. J. Travel Med. 2002, 9:153-155.
25. Khawplod P., Wilde H., Tepsumethanon S., Limusanno S., Tantawichien T., Chomchey P., Ayuthaya A.B., Wangroonsarb Y. Prospective immunogenicity study of multiple intradermal injections of rabies vaccine in an effort to obtain an early immune response without the use of immunoglobulin. Clin. Infect. Dis. 2002, 35:1562-1565.
26. Khawplod P., Wilde H., Sirikwin S., Benjawongkulchai M., Limusanno S., Jaijaroensab W., Chiraguna N., Supich C., Wangroongsarb Y., Sitprija V. Revision of the Thai Red Cross intradermal rabies post-exposure regimen by eliminating the 90-day booster injection. Vaccine 2006, 24:3084-3086.
27. Knobel D.L., Cleaveland S., Coleman P.G., Fevre E.M., Meltzer M.I., Miranda M.E., Shaw A., Zinsstag J., Meslin F.X. Re-evaluating the burden of rabies in Africa and Asia. Bull. World Health Organ. 2005, 83:360-368.
28. Kositprapa C., Limsuwun K., Wilde H., Jaijaroensup W., Saikasem A., Khawplod P., Kri-aksorn U., Supich C. Immune response to simulated postexposure rabies booster vaccinations in volunteers who received preexposure vaccinations. Clin. Infect. Dis. 1997, 25:614-616.
29. Manning S.E., Rupprecht C.E., Fishbein D., Hanlon C.A., Lumlertdacha B., Guerra M., Meltzer M.I., Dhankhar P., Vaidya S.A., Jenkins S.R., Sun B., Hull H.F. Human rabies prevention-United States, 2008: Recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm. Rep. 2008, 57:1-28.
30. Mansfield K.L., Burr P.D., Snodgrass D.R., Sayers R., Fooks A.R. Factors affecting the serological response of dogs and cats to rabies vaccination. Vet. Rec. 2004, 154:423-426.
31. Murray K.O., Holmes K.C., Hanlon C.A. Rabies in vaccinated dogs and cats in the United States, 1997-2001. J. Am. Vet. Med. Assoc. 2009, 235:691-695.
32. Nicolas J.F., Guy B. Intradermal, epidermal and transcutaneous vaccination: From immunology to clinical practice. Expert Rev. Vaccines 2008, 7:1201-1214.
33. Phanuphak P., Khawplod P., Sirivichayakul S., Siriprasomsub W., Ubol S., Thaweepathomwat M. Humoral and cell-mediated immune responses to various economical regimens of purified Vero cell rabies vaccine. Asian Pac. J. Allergy Immunol. 1987, 5:33-37.
34. Ratanavongsiri J., Sriwanthana B., Ubol S., Phanuphak P. Cell-mediated immune response following intracutaneous immunisation with human diploid cell rabies vaccine. Asian Pac. J. Allergy Immunol. 1985, 3:187-190.
35. Rupprecht C.E., Hanlon C.A., Hemachudha T. Rabies re-examined. Lancet Infect. Dis. 2002, 2:327-343.
36. Rupprecht C.E., Briggs D., Brown C.M., Franka R., Katz S.L., Kerr H.D., Lett S.M., Levis R., Meltzer M.I., Schaffner W., Cieslak P.R. Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: Recommendations of the advisory committee on immunization practices. MMWR Recomm. Rep. 2010, 59:1-9.
37. Sage G., Khawplod P., Wilde H., Lobaugh C., Hemachudha T., Tepsumethanon W., Lumlertdaecha B. Immune response to rabies vaccine in Alaskan dogs: Failure to achieve a consistently protective antibody response. Trans. R. Soc. Trop. Med. Hyg. 1993, 87:593-595.
38. Saraya A., Wacharapluesadee S., Khawplod P., Tepsumethanon S., Briggs D., Asawavichienjinda T., Hemachudha T. A preliminary study of chemo- and cytokine responses in rabies vaccine recipients of intradermal and intramuscular regimens. Vaccine 2010, 28:4553-4557.
39. Shantavasinkul P., Tantawichien T., Jaijaroensup W., Lertjarutorn S., Banjongkasaena A., Wilde H., Sitprija V. A 4-site, single-visit intradermal postexposure prophylaxis regimen for previously vaccinated patients: Experiences with >5000 patients. Clin. Infect. Dis. 2010, 51:1070-1072.
40. Shantavasinkul P., Tantawichien T., Wacharapluesadee S., Jeamanukoolkit A., Udomchaisakul P., Chattranukulchai P., Wongsaroj P., Khawplod P., Wilde H., Hemachudha T. Failure of rabies postexposure prophylaxis in patients presenting with unusual manifestations. Clin. Infect. Dis. 2010, 50:77-79.
41. Shantavasinkul P., Tantawichien T., Wilde H., Sawangvaree A., Kumchat A., Ruksaket N., Lohsoonthorn V., Khawplod P. Postexposure rabies prophylaxis completed in 1week: Preliminary study. Clin. Infect. Dis. 2010, 50:56-60.
42. Shill M., Baynes R.D., Miller S.D. Fatal rabies encephalitis despite appropriate post-exposure prophylaxis. A case report. N. Engl. J. Med. 1987, 316:1257-1258.
43. Siwasontiwat D., Lumlertdacha B., Polsuwan C., Hemachudha T., Chutvongse S., Wilde H. Rabies: Is provocation of the biting dog relevant for risk assessment?. Trans. R. Soc. Trop. Med. Hyg. 1992, 86:443.
44. Smith P.C., Lawhaswasdi K., Vick W.E., Stanton J.S. Enzootic rabies in rodents in Thailand. Nature 1968, 217:954-955.
45. Sriaroon C., Daviratanasilpa S., Sansomranjai P., Khawplod P., Hemachudha T., Khamoltham T., Wilde H. Rabies in a Thai child treated with the eight-site post-exposure regimen without rabies immune globulin. Vaccine 2003, 21:3525-3526.
46. Suwansrinon K., Jaijaroensup W., Wilde H., Sitprija V. Is injecting a finger with rabies immunoglobulin dangerous?. Am. J. Trop. Med. Hyg. 2006, 75:363-364.
47. Suwansrinon K., Jaijareonsup W., Wilde H., Benjavongkulchai M., Sriaroon C., Sitprija V. Sex- and age-related differences in rabies immunoglobulin hypersensitivity. Trans. R. Soc. Trop. Med. Hyg. 2007, 101:206-208.
48. Tantawichien T., Benjavongkulchai M., Wilde H., Jaijaroensup W., Siakasem A., Chareonwai S., Yountong C., Sitprija V. Value of skin testing for predicting reactions to equine rabies immune globulin. Clin. Infect. Dis. 1995, 21:660-662.
49. Tantawichien T., Benjavongkulchai M., Limsuwan K., Khawplod P., Kaewchompoo W., Chomchey P., Sitprija V. Antibody response after a four-site intradermal booster vaccination with cell-culture rabies vaccine. Clin. Infect. Dis. 1999, 28:1100-1103.
50. Tantawichien T., Supit C., Khawplod P., Sitprija V. Three-year experience with 4-site intradermal booster vaccination with rabies vaccine for postexposure prophylaxis. Clin. Infect. Dis. 2001, 33:2085-2087.
51. Tepsumethanon V.L.B., Mitmoonpitak C. Does history-taking help predict rabies diagnosis in dogs?. Asian Biomed. 2010, 4:811-815. Brief communication (original).
52. Tepsumethanon W., Polsuwan C., Lumlertdaecha B., Khawplod P., Hemachudha T., Chutivongse S., Wilde H., Chiewbamrungkiat M., Phanuphak P. Immune response to rabies vaccine in Thai dogs: A preliminary report. Vaccine 1991, 9:627-630.
53. Tepsumethanon V., Lumlertdacha B., Mitmoonpitak C., Fagen R., Wilde H. Fluorescent antibody test for rabies: Prospective study of 8,987 brains. Clin. Infect. Dis. 1997, 25:1459-1461.
54. Tepsumethanon V., Lumlertdacha B., Mitmoonpitak C., Sitprija V., Meslin F.X., Wilde H. Survival of naturally infected rabid dogs and cats. Clin. Infect. Dis. 2004, 39:278-280.
55. Thisyakorn U., Pancharoen C., Ruxrungtham K., Ubolyam S., Khawplod P., Tantawichien T., Phanuphak P., Wilde H. Safety and immunogenicity of preexposure rabies vaccination in children infected with human immunodeficiency virus type 1. Clin. Infect. Dis. 2000, 30:218.
56. Thisyakorn U., Pancharoen C., Wilde H. Immunologic and virologic evaluation of HIV-1-infected children after rabies vaccination. Vaccine 2001, 19:1534-1537.
57. Warrell M.J., Nicholson K.G., Warrell D.A., Suntharasamai P., Chanthavanich P., Viravan C., Sinhaseni A., Chiewbambroongkiat M.K., Pouradier-Duteil X., Xueref C., et al. Economical multiple-site intradermal immunisation with human diploid-cell-strain vaccine is effective for post-exposure rabies prophylaxis. Lancet 1985, 1:1059-1062.
58. Warrell D.A., Gutiérrez J.M. World Health Organization. Rabies and envenomings: A neglected public health issue: Report of a consultative meeting, World Health Organization, Geneva, 10 January 2007 2007, World Health Organization, Geneva.
59. Wilde H. Failures of post-exposure rabies prophylaxis. Vaccine 2007, 25:7605-7609.
60. Wilde H., Choomkasien P., Hemachudha T., Supich C., Chutivongse S. Failure of rabies postexposure treatment in Thailand. Vaccine 1989, 7:49-52.
61. Wilde H., Bhanganada K., Chutivongse S., Siakasem A., Boonchai W., Supich C. Is injection of contaminated animal bite wounds with rabies immune globulin a safe practice?. Trans. R. Soc. Trop. Med. Hyg. 1992, 86:86-88.
62. Wilde H., Sirikawin S., Sabcharoen A., Kingnate D., Tantawichien T., Harischandra P.A., Chaiyabutr N., de Silva D.G., Fernando L., Liyanage J.B., Sitprija V. Failure of postexposure treatment of rabies in children. Clin. Infect. Dis. 1996, 22:228-232.
63. Wilde H., Tipkong P., Khawplod P. Economic issues in postexposure rabies treatment. J. Travel Med. 1999, 6:238-242.
64. Wilde H., Khawplod P., Hemachudha T., Sitprija V. Postexposure treatment of rabies infection: Can it be done without immunoglobulin?. Clin. Infect. Dis. 2002, 34:477-480.
65. Wimalaratne O. Is it necessary to give rabies post-exposure treatment after rodent (rats, mice, squirrels and bandicoots) bites?. Ceylon Med. J. 1997, 42:144.